Tatsuya Yamamoto Selected Research

Tatsuya Yamamoto Research Topics

Disease

16	Parkinson Disease (Parkinson's Disease) 12/2023 - 06/2005
14	Neoplasms (Cancer) 01/2022 - 09/2002
7	Multiple System Atrophy 12/2022 - 06/2005
7	Constipation 01/2020 - 06/2005
4	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2015
3	Dyskinesias (Dyskinesia) 06/2020 - 10/2019
3	Urinary Retention 01/2013 - 08/2005
2	Pathologic Constriction (Stenosis) 12/2022 - 11/2022
2	Hematoma 12/2022 - 01/2008
2	Movement Disorders (Movement Disorder) 01/2022 - 01/2020
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022 - 06/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2021
2	Inflammation (Inflammations) 10/2021 - 06/2021
2	Orthostatic Hypotension (Postural Hypotension) 04/2020 - 08/2006
2	Overactive Urinary Bladder (Overactive Bladder) 10/2019 - 08/2013
2	Brain Neoplasms (Brain Tumor) 01/2019 - 10/2013
2	Polyuria 06/2012 - 04/2005
2	Cognitive Dysfunction 06/2012 - 01/2011
2	Motor Disorders 06/2012 - 01/2011
2	Spinal Cord Diseases 08/2006 - 10/2005
2	Underactive Urinary Bladder 08/2006 - 08/2005
1	Spinal Stenosis (Stenosis, Spinal) 12/2022
1	Surgical Wound Infection 12/2022
1	Hypoventilation 12/2022
1	Hypercapnia 12/2022
1	Medulloblastoma 01/2022
1	Parkinsonian Disorders (Parkinsonism) 01/2022
1	Corticobasal Degeneration 01/2022
1	Colonic Neoplasms (Colon Cancer) 06/2021
1	Congenital Abnormalities (Deformity) 01/2021
1	Aspiration Pneumonia 01/2021
1	Autolysis 01/2021
1	Lymphatic Metastasis 09/2020
1	Seminoma 09/2020
1	Lymphadenopathy 09/2020
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2020
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 04/2020
1	Lower Urinary Tract Symptoms 01/2020
1	Weight Cycling 01/2020
1	Hallucinations (Hallucination) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Insulin Resistance 01/2020
1	Deglutition Disorders (Dysphagia) 01/2020
1	Myelolipoma 02/2019

Drug/Important Bio-Agent (IBA)

9	Levodopa (L Dopa)FDA LinkGeneric 06/2020 - 12/2009
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2005
5	Cholinergic Antagonists (Anticholinergics)IBA 08/2013 - 01/2011
3	Progesterone Receptors (Progesterone Receptor)IBA 06/2021 - 03/2003
3	Cholinergic Agents (Cholinergics)IBA 01/2013 - 08/2005
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2022 - 06/2020
2	ErbB Receptors (EGF Receptor)IBA 06/2021 - 03/2016
2	Heme (Haem)IBA 06/2021 - 03/2016
2	Cisplatin (Platino)FDA LinkGeneric 06/2021 - 04/2009
2	Contrast MediaIBA 05/2014 - 10/2013
2	Myelin Basic ProteinIBA 01/2013 - 12/2005
2	calcium polycarbophil (polycarbophil)IBA 08/2007 - 08/2006
2	Arginine Vasopressin (Argipressin)IBA 01/2007 - 04/2005
2	Prealbumin (Transthyretin)IBA 02/2006 - 01/2006
2	ChromatinIBA 03/2005 - 09/2002
2	Keratins (Keratin)IBA 03/2003 - 09/2002
2	DesminIBA 03/2003 - 09/2002
1	S 10 (S-10)IBA 12/2022
1	Carbon DioxideIBA 12/2022
1	ParaffinIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Inosine Monophosphate (IMP)IBA 01/2022
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 10/2021
1	Carbon MonoxideIBA 06/2021
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 06/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2021
1	arginyl- threonyl- prolyl- prolyl- prolyl- seryl- glycine (SP 6)IBA 01/2021
1	Cytidine Monophosphate (CMP)IBA 01/2021
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 06/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 06/2020
1	Monoamine Oxidase (MAO)IBA 06/2020
1	Dopamine (Intropin)FDA LinkGeneric 06/2020
1	Hexachlorobenzene (HCB)IBA 04/2020
1	hydroxide ionIBA 04/2020
1	Chemotactic FactorsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Oxyhemoglobins (Oxyhemoglobin)IBA 10/2019
1	fesoterodine FDA Link 10/2019
1	indium trichloride (indium chloride)IBA 02/2019
1	ChloridesIBA 02/2019
1	Hormones (Hormone)IBA 02/2019
1	pembrolizumabIBA 01/2019

Therapy/Procedure

13	Deep Brain Stimulation 12/2023 - 05/2012
10	Therapeutics 09/2020 - 01/2004
4	Radiotherapy 01/2022 - 04/2009
3	Drug Therapy (Chemotherapy) 01/2022 - 03/2017
2	Decompression 12/2022 - 11/2022
1	Reoperation 12/2022
1	Aftercare (After-Treatment) 01/2022
1	Nephrectomy 01/2022
1	Heterologous Transplantation (Xenotransplantation) 06/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Spinal Fusion (Spondylosyndesis) 01/2021
1	Orchiectomy (Orchidectomy) 09/2020